RxDoctor Payments Data

Byron Strother

Psychiatry · Morganton, NCNPI 1174582563

Payments from drug & device makers

$904in general payments, 2019–2025

Across 47 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$179
  • Teva Pharmaceuticals USA, Inc.$131
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$128
  • AbbVie$97
  • Alkermes, Inc.$82
  • Takeda Pharmaceuticals U.S.A., Inc.$65
  • plus $221 from 7 others

What the payments were for

  • Food & beverage$86596%
  • Education$394%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$904 in reported general payments places this provider in the 70th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,050
Medicare patients
53
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$17,321
RisperdalRisperidone14$8,820
Lurasidone Hcl35$5,764
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine191$5,509
Clonazepam352$4,075
Lisdexamfetamine Dimesylate18$3,923
Aripiprazole81$3,878
Lamotrigine ErLamotrigine23$3,719
Buspirone Hcl306$3,159
Bupropion XlBupropion Hcl134$2,679
Gabapentin189$2,508
Alprazolam415$2,378
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine37$1,933
Zolpidem Tartrate220$1,357
Trazodone Hcl308$1,319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$179$17,32112 claims
Johnson & JohnsonRisperdal$25$8,82014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Morganton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →